Selectivity in new  -adrenergic blocking agents. (3-Amino-2-hydroxypropoxy)benzamides.
D000319:Adrenergic beta-Antagonists / Q000138:chemical synthesis* / Q000494:pharmacology; D000605:Amino Alcohols / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D001549:Benzamides / Q000138:chemical synthesis / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D009928:Organ Specificity; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000138:chemical synthesis / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D001549:Benzamides; D011437:Propylamines; D011941:Receptors, Adrenergic; D014665:Vasodilator Agents; D011433:Propranolol; D007545:Isoproterenol